參考文獻 |
1. Vanunu, O., et al., Associating Genes and Protein Complexes with Disease via Network Propagation. PLoS Computational Biology, 2010. 6(1): p. e1000641.
2. Goh, K.-I., et al., The human disease network. PNAS, 2007. 104(21): p. 8685-8690.
3. Elavsky, S. and E. McAuley, Personality, Menopausal Symptoms, and Physical Activity Outcomes in Middle-Aged Women. Pers Individ Dif, 2009. 46(2): p. 123-128.
4. Solimene, M.C., Coronary heart disease in women: a challenge for the 21st century. Clinics, 2010. 65(1): p. 99-106.
5. Willett, W.C., Balancing life-style and genomics research for disease prevention. Science, 2002. 296(5568): p. 695-698.
6. Islam, T.M., et al., Age-related associations of hypertension and diabetes mellitus with chronic kidney disease. BMC Nephrology, 2009. 10(17).
7. Shim, Y.H., Cardioprotection and ageing. Korean J Anesthesiol, 2010. 58(3): p. 223-230.
8. Berry, S.D., et al., Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc, 2010. 58(4): p. 783-787.
9. Loscalzo, J., I. Kohane, and A.L. Barabasi, Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol, 2007. 3: p. 124.
10. Buck, C.J., 2001 ICD-9-CM, volumes 1, 2, and 3. 2003.
11. Ravasz, E., et al., Hierarchical organization of modularity in metabolic networks. Science, 2002. 297(5586): p. 1151-1555.
12. Barabási, A.-L. and Z.N. Oltvai, Network biology: understanding the cell's functional organization. Nature Reviews Genetics, 2004. 5(2): p. 101-113.
13. Elston, R.C., J.M. Olson, and L. Palmer, Biostatistical genetics and genetic epidemiology. Wiley reference series in biostatistics. 2002, Chichester, England ;: New York, NY Wiley. xxiv, 831 p.
14. Fleiss, J.L., B.A. Levin, and M.C. Paik, Statistical methods for rates and proportions. 3rd ed. Wiley series in probability and statistics. 2003, Hoboken, N.J.: J. Wiley. xxvii, 760 p.
15. Kraemer, H.C., Reconsidering the odds ratio as a measure of 2x2 association in a population. Stat Med, 2004. 23(2): p. 257-70.
16. Knapp, R.G. and M.C. Miller, Clinical epidemiology and biostatistics. National medical series for independent study. 1992, Malvern, Pa ; Baltimore London: Harwal Pub. Co ; Williams & Wilkins. xi, 435 p.
17. Wassertheil-Smoller, S., Biostatistics and epidemiology : a primer for health and biomedical professionals. 3rd ed. 2004, New York: Springer-Verlag. xvi, 243 p.
18. OSVOLL, P.O. and T. WOLDBáK, Distribution and skewness of occupational exposure sets of measurements in the norwegian industry. Elsevier Science Ltd, 1999. 43(6): p. 421-428.
19. Sulewski, P., The three-folded skewness test, when a sample size is small. COMPUTATIONAL METHODS IN SCIENCE AND TECHNOLOGY, 2009. 15(2): p. 195-201.
20. Hidalgo, C.s.A., et al., A Dynamic Network Approach for the Study of Human Phenotypes. PLoS Computatioanl Biology, 2009. 5(4).
21. Wood, L.D., et al., The genomic landscapes of human breast and coloretal cancers. Science, 2007. 318: p. 1108-1113.
22. Swerdlow, A.J. and M.E. Jones, Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. Journal of the National Cancer Institute, 2005. 97(5): p. 375-384.
23. Yıldırım, M.A., et al., Drug target network. NATURE BIOTECHNOLOGY, 2007. 25(10): p. 1119-1126.
24. Perez, E.A., Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Annals of Oncology, 2007. 18(8): p. 26-35.
25. DeMichele, A., et al., Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study. JOURNAL OF CLINICAL ONCOLOGY, 2008. 26: p. 4151-4159.
26. Thu¨rlimann, B., Reducing the risk of early recurrence in hormone-responsive breast cancer. Annals of Oncology, 2007. 18(8): p. 8-17.
27. Nelson, H.D., et al., Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Annals of Internal Medicine, 2009. 151(10): p. 703-715.
|